title: Familial Alzheimer disease among Caribbean Hispanics: a reexamination of its association with APOE.
abstract: OBJECTIVE
  To reexamine the association between the apolipoprotein E epsilon4 allele (APOE epsilon4) and familial Alzheimer disease (AD), and to search for novel genes that may be associated with susceptibility in Caribbean Hispanic families with a history of AD.
  
  
  METHODS
  Families were identified in Caribbean Hispanic communities in the greater New York City area, the Dominican Republic, and Puerto Rico. Each family in the study cohort included at least 2 living relatives with a history of dementia. All family members underwent neuropsychological testing and medical and neurological examinations to establish the presence or absence of dementia and to specify the type of dementia.
  
  
  RESULTS
  Over a 2(1/2)-year period, 203 families were identified. Of these, 19 families had at least 1 family member with onset of dementia before age 55 years, with 8 of the 19 families showing an association with a previously unreported presenilin mutation. Multiple cases of AD were identified in 29 families. Overall, there were 236 affected sibling pairs with AD available for analysis. The average age at onset was 74 years. The presence of APOE epsilon4 was strongly associated with AD.
  
  
  CONCLUSIONS
  Both early-onset and late-onset familial AD occur in Caribbean Hispanics. In contrast to sporadic AD, late-onset familial AD among Caribbean Hispanics is strongly associated with APOE epsilon4. Future attempts to identify additional susceptibility genes should consider the effects of APOE epsilon4.
authors.affiliation: Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Gertrude H. Sergievsky Center, College of Physicians and Surgeons, Columbia University, 630 W 168th St, New York, NY 10032, USA. rpm2@columbia.edu
authors.forename: Stavra N
authors.initials: SN
authors.lastname: Romas
authors.forename: Vincent
authors.initials: V
authors.lastname: Santana
authors.forename: Jennifer
authors.initials: J
authors.lastname: Williamson
authors.forename: Alejandra
authors.initials: A
authors.lastname: Ciappa
authors.forename: Joseph H
authors.initials: JH
authors.lastname: Lee
authors.forename: Haydee Z
authors.initials: HZ
authors.lastname: Rondon
authors.forename: Pedro
authors.initials: P
authors.lastname: Estevez
authors.forename: Rafael
authors.initials: R
authors.lastname: Lantigua
authors.forename: Martin
authors.initials: M
authors.lastname: Medrano
authors.forename: Mayobanex
authors.initials: M
authors.lastname: Torres
authors.forename: Yaakov
authors.initials: Y
authors.lastname: Stern
authors.forename: Benjamin
authors.initials: B
authors.lastname: Tycko
authors.forename: Richard
authors.initials: R
authors.lastname: Mayeux
mesh_terms: D000368:Aged; D000544:Alzheimer Disease / Q000208:ethnology* / Q000235:genetics; D053327:Apolipoprotein E4; D001057:Apolipoproteins E / Q000235:genetics; D017691:Caribbean Region / Q000208:ethnology; D005192:Family Health; D005260:Female; D005787:Gene Frequency; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006630:Hispanic or Latino / Q000706:statistics & numerical data*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009518:New York / Q000453:epidemiology; D010375:Pedigree
chemical_list: D053327:Apolipoprotein E4; D001057:Apolipoproteins E